High-grade serous ovarian carcinoma, HGSOC
Conditions
Interventions
Residual lesion group:None
No residual lesion group:None
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 2. Multimodal magnetic resonance examination before treatment; 3. NACT candidates (patients with high disease burden (Fagotti score >= 8 points based on laparoscopic diagnosis, peritoneal dissemination, > 2 intestinal resections, mesenteric retraction, extensive small bowel involvement, stage IVB, with the exception of liver, spleen, and isolated cardiorenal lymph node metastases); 4. Patients who have received more than one cycle of NACT prior to IDS; 5. Documented follow-up for at least 6 months after chemotherapy.
Exclusion criteria
Exclusion criteria: Patients with other primary malignancies, pregnant, treated with PDS, and prior history of other chemotherapy or radiotherapy. In addition, patients who lost follow-up during chemotherapy cycles or who had missing clinical and imaging data or poor image quality were also excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Residual tumor; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival;Overall survival; | — |
Countries
China
Contacts
Public ContactXiao Zhibo
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed